Cargando…
Ectopic Pregnancy-Derived Human Trophoblastic Stem Cells Regenerate Dopaminergic Nigrostriatal Pathway to Treat Parkinsonian Rats
BACKGROUND: Stem cell therapy is a potential strategy to treat patients with Parkinson’s disease (PD); however, several practical limitations remain. As such, finding the appropriate stem cell remains the primary issue in regenerative medicine today. We isolated a pre-placental pluripotent stem cell...
Autores principales: | Lee, Tony Tung-Yin, Tsai, Cheng-Fang, Hsieh, Tsung-Hsun, Chen, Jia-Jin Jason, Wang, Yu-Chih, Kao, Mi-Chun, Wu, Ruey-Meei, Singh, Sher, Tsai, Eing-Mei, Lee, Jau-Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528662/ https://www.ncbi.nlm.nih.gov/pubmed/23285066 http://dx.doi.org/10.1371/journal.pone.0052491 |
Ejemplares similares
-
Dynamic Trk and G Protein Signalings Regulate Dopaminergic Neurodifferentiation in Human Trophoblast Stem Cells
por: Tsai, Eing-Mei, et al.
Publicado: (2015) -
Retraction: Ectopic Pregnancy-Derived Human Trophoblastic Stem Cells Regenerate Dopaminergic Nigrostriatal Pathway to Treat Parkinsonian Rats
Publicado: (2021) -
Unbalanced calcium channel activity underlies selective vulnerability of nigrostriatal dopaminergic terminals in Parkinsonian mice
por: Sgobio, Carmelo, et al.
Publicado: (2019) -
Naringin: A Protector of the Nigrostriatal Dopaminergic Projection
por: Jung, Un Ju, et al.
Publicado: (2014) -
Clinical Features Indicating Nigrostriatal Dopaminergic Degeneration in Drug-Induced Parkinsonism
por: Lee, Seung Ha, et al.
Publicado: (2017)